Surgical reoxygenation injury of the myocardium in cyanotic patients: Clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass

General Thoracic and Cardiovascular Surgery

Volumn 60, Issue 9, 2012, Pages 549-556

  Morita, Kiyozo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidants reserve capacity; Cardiopulmonary bypass; Cyanotic heart disease; Reoxygenation injury

Indexed keywords

8 ISOPROSTANE; ALPHA GLUTAMATE TRANSFERASE; CATALASE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFERASE; TROPONIN I; UNCLASSIFIED DRUG;

AGE; BLOOD OXYGEN TENSION; CARDIOPULMONARY BYPASS; CLINICAL FEATURE; CYANOTIC HEART DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; FLOW RATE; HEART MUSCLE REPERFUSION; HUMAN; HYPOXIA; LIPID PEROXIDATION; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRESSURE MEASUREMENT; REOXYGENATION; REPERFUSION INJURY; REVIEW; SURGICAL INJURY; TREATMENT PLANNING;

ANIMALS; ANOXIA; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CYANOSIS; HUMANS; HYPEROXIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 84866052299     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-012-0115-2     Document Type: Review

References (37)

1. Baker JE, Curry BD, Olinger GN, Gross GJ. Increased tolerance of the chronically hypoxic immature heart to ischemia-contribution of the KATP channel. Circulation. 1997;95:1278-85.
2. Silverman NA, Kohler J, Levitsky S, Pavel DG, Fang RB, Feinberg H. Chronic hypoxemia decreases global ventricular function and predisposes to the depletion of high-energy phosphates during cardiac arrest: implications for surgical repair of cyanotic congenital heart defects. Ann Thorac Surg. 1984;37: 304-8.
3. Fujiwara T, Kurtts T, Anderson W, Heinle J, Mayer JE Jr. Myocardial protection in cyanotic neonatal lambs. J Thorac Cardiovasc Surg. 1988;96:700-10.
4. Milano G, Corno AF, Samaja M, Morel S, Vassalli G, von Segesser LK. Daily reoxygenation decreases myocardial injury and improves post-ischemic recovery after chronic hypoxia. Eur J Cardio Thorac Surg. 2010;37:942-9.
5. Corno AF, Milano G, Samaja M, Tozzi P, von Segesser LK. Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg. 2002;124:105-11.
6. del Nido PJ, Mickle DAG, Wilson GJ, Benson LN, Weisel RD, Coles JG, et al. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1988;95:223-9.
7. Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman MS. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation. 2001;103:1551-6.
8. Najm HK, Wallen WJ, Belanger MP, Williams WG, Coles JG, Van Arsdell GS, et al. Does the degree of cyanosis affect myocardial adenosine triphosphatase levels and function in children undergoing surgical procedures for sqw congenital heart disease? J Thorac Cardiovasc Surg. 2000;119:515-24.
9. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA Jr, et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation 1986;74:III 130-3
10. Gauduel Y, Menasche P, Duvelleroy M. Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: relationship with oxygen-induced lipid peroxidation. Gen Physiol Biophys. 1989;8:327-40.
11. Boveris A. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv Exp Med Biol. 1977;78:61-82.
12. Buckberg GD. Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc. 1995;110:1164-70.
13. Teoh KH, Mickle DA, Weisel RD, Li RK, Tumiati LC, Coles JG, et al. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg. 1992;104:159-64.
14. Del Nido PJ, Mickle DAG, Wilson G, Benson LN, Coles JG, Trusler GA, et al. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. Circulation. 1987;76: 174-9.
15. Saker M, Mokhtari NS, Merzouk SA, Merzouk H, Belarbi B, Narce M. Oxidant and antioxidant status in mothers and their newborns according to birthweight. Eur J Obstet Gynecol Reprod Biol. 2008;141:95-9.
16. Loui A, Raab A, Maier RF, Bratter P, Obladen M. Trace elements and antioxidant enzymes in extremely low birthweight infants. J Trace Elem Med Biol. 2010;24:111-8.
17. Vento M, Sastre J, Asensi MA, Vina J. Room-air resuscitation causes less damage to heart and kidney than 100 % oxygen. Am J Respir Crit Care Med. 2005;172:1393-8.
18. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic cross clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis. J Thorac Cardiovasc Surg. 1995;110:1235-44.
19. Morita K, Ihnken K, Buckberg GD. Studies of hypoxemic/ reoxygenation injury: with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis: a new conceptof controlled cardiac reoxygenation. J Thorac Cardiovasc Surg. 1995;110(4 Pt 2):1265-73.
20. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest. 1994;93:2658-66.
21. Zhang J, Jamieson WR, Sadeghi H, Gillespie K, Marier JR, Mickleson H, et al. Strategies of myocardial protection for operation in chronic model of cyanotic heart disease. Ann Thorac Surg. 1998;66:1507-13.
22. Allen BS, Rahman S, Ilbawi MN, Kronon M, Bolling KS, Halldorsson AO, et al. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg. 1997;64:1381-8.
23. Bulutcu FS, Bayndir O, Polat B, Yalcin Y, ÖZbek U, Cakali E. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children? J Cardiothorac Vasc Anesth. 2002;16:330-3.
24. Modi P, Imura H, Caputo M, Pawade A, Parry A, Angelini GD, et al. Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg. 2002;124:1035-6.
25. Aliakbar S, Brown PR, Bidwell D, Nicolaides KH. Human erythrocytes superoxide dismutase in adults, neonates and normal, hypoxaemic, anaemic and chromosomally abnormal fetuses. Clin Biochem. 1993;26:109-15.
26. Casado A, de la Torre R, Lopes-Fernandez ME. Copper/zinc superoxide dismutase activity in newborns and young people in Spain. Indian J Med Res. 2007;125:655-60.
27. Toraman F, Evrenkaya S, Senay S, Karabulut H, Alhan C. Adjusting oxygen fraction to avoid hyperoxemia during cardiopulmonary bypass. Asian Cardiovasc Thorac Ann. 2007;15: 313-6.
28. Zhu ZQ, Su ZK, Zhu DM. The role of graded reoxygenation with cardiopulmonary bypass in prevention of reoxygenation injury and its safety. Zhonghua Yi Xue Za Zhi. 2005;85(9):614-7.
29. Siegmund B, Klietz T, Schwartz P, Piper HM. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol Heart Circ Physiol. 1991; 260:H426-35.
30. Caputo M, Mokhtari A, Rogers CA, Panayiotou N, Chen Q, Ghorbel MT, et al. The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2009;138(1):206-14.
31. Jacobson RM, Feinstein AR. Oxygen as a cause of blindness in premature infants: "autopsy" of a decade of errors in clinical epidemiologic research. J Clin Epidemiol. 1992;45:1265-87.
32. Bandali KS, Belanger MP, Wittnichi C. Does hyperoxia affect glucose regulation and transport in the newborn? J Thorac Cardiovasc Surg. 2003;126:1730-5.
33. Joachimsson PO, Sjoberg F, Forsman M, Johansson M, Ahn HC, Rutberg H. Adverse effects of hyperoxemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:812.
34. Ihnken K, Winkler A, Schlensak C, Sarai K, Neidhart G, Unkelbach U, et al. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg. 1998;116: 327-34.
35. Abdel-Rahman U, Risteski P, Tizi K, Kerscher S, Behjati S, Zwicker K, et al. Hypoxic reoxygenation during initial reperfusion attenuates cardiac dysfunction and limits ischemia-reperfusion injury after cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg. 2009;137:978-82.
36. Abdel-Rahman U, Aybek T, Moritz A, Kleine P, Matheis G. Graded reoxygenation limits lipid peroxidation during surgical reperfusion. Med Sci Monit. 2003;9:CR389-91.
37. Nollert G, Nagashima M, Bucerius J, Shin'oka T, Lidov HG, du Plessis A, et al. Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1999;117:1172-9.